Pliant Therapeutics Stock Quote PLRX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.6987

Bid

1.65

Ask

1.69

Volume

7,019

0.00 Day's Range 0.00

1.26 52 Week Range 16.52

Market Cap

104.022M

Previous Close

1.70

Open

Last Trade

1.6987

Last Trade Time

09:10:15

Financial Volume

VWAP

Average Volume (3m)

2,584,952

Shares Outstanding

61,236,291

Dividend Yield

PE Ratio

-0.50

Earnings Per Share (EPS)

-3.43

Revenue

Net Profit

-210.3M

Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

pliantrx.com.

Headquarters

Dover, Delaware, USA

Founded

Pliant Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PLRX. The last closing price for Pliant Therapeutics was $1.70. Over the last year, Pliant Therapeutics shares have traded in a share price range of $ 1.26 to $ 16.52.

Pliant Therapeutics currently has 61,236,291 shares outstanding. The market capitalization of Pliant Therapeutics is $104.10 million. Pliant Therapeutics has a price to earnings ratio (PE ratio) of -0.50.

Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date...

Form 8-K - Current report

Form 8-A12B - Registration of securities [Section 12(b)]

Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement

SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results

Discontinuation of BEACON-IPF following DSMB and outside expert panel recommendation SOUTH SAN FRANCISCO...

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX...

Form 8-K - Current report

Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0687	4.21472392638	1.63	1.775	1.455	1832426	1.60536293	CS
4	-1.3613	-44.4869281046	3.06	3.46	1.26	3678804	1.99796734	CS
12	-11.6413	-87.2661169415	13.34	14.255	1.26	2584952	3.5094826	CS
26	-10.9613	-86.5821484992	12.66	16.1	1.26	1415146	5.46873645	CS
52	-13.5013	-88.8243421053	15.2	16.52	1.26	931077	7.300591	CS
156	-6.3013	-78.76625	8	36.64	1.26	812171	15.72585882	CS
260	-20.8013	-92.4502222222	22.5	43.92	1.26	556077	16.48131306	CS

PLRX - Frequently Asked Questions (FAQ)

What is the current Pliant Therapeutics share price?

The current share price of Pliant Therapeutics is $ 1.6987

How many Pliant Therapeutics shares are in issue?

Pliant Therapeutics has 61,236,291 shares in issue

What is the market cap of Pliant Therapeutics?

The market capitalisation of Pliant Therapeutics is USD 104.1M

What is the 1 year trading range for Pliant Therapeutics share price?

Pliant Therapeutics has traded in the range of $ 1.26 to $ 16.52 during the past year

What is the PE ratio of Pliant Therapeutics?

The price to earnings ratio of Pliant Therapeutics is -0.5

What is the reporting currency for Pliant Therapeutics?

Pliant Therapeutics reports financial results in USD

What is the latest annual profit for Pliant Therapeutics?

The latest annual profit of Pliant Therapeutics is USD -210.3M

What is the registered address of Pliant Therapeutics?

The registered address for Pliant Therapeutics is 850 NEW BURTON ROAD SUITE 201, DOVER, DELAWARE, 19904

What is the Pliant Therapeutics website address?

The website address for Pliant Therapeutics is pliantrx.com.

Which industry sector does Pliant Therapeutics operate in?

Pliant Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 78.3889 (0.00%)	0
AADIAadi Bioscience Inc	$ 2.10 (0.00%)	900
AACGATA Creativity Global	$ 0.85 (0.00%)	0
AACBUArtius II Acquisition Inc	$ 10.05 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 78.3889 (0.00%)	0
AADIAadi Bioscience Inc	$ 2.10 (0.00%)	900
AACGATA Creativity Global	$ 0.85 (0.00%)	0
AACBUArtius II Acquisition Inc	$ 10.05 (0.00%)	0
SYRSSyros Pharmaceuticals Inc	$ 0.0858 (0.00%)	106.44M
LITMSnow Lake Resources Ltd	$ 0.4162 (0.00%)	41.71M
GNPXGenprex Inc	$ 0.40 (0.00%)	27.63M
SCNXScienture Holdings Inc	$ 2.48 (0.00%)	24.26M
BONBon Natural Life Ltd	$ 0.6126 (0.00%)	20.03M